期刊文献+

氨溴索注射剂对多索茶碱在大鼠体内药动学的影响 被引量:9

Effect of ambroxol injection on pharmacokinetics of doxophylline in rabbits
原文传递
导出
摘要 目的研究氨溴索对多索茶碱(DP)在大鼠体内的药动学参数的影响。方法采用HPLC法测定16只大鼠单独给予DP和合并盐酸氨溴索给药后DP以及其代谢产物茶碱(TP)的血药浓度,用DAS药动学软件对DP血药浓度-时间数据采用非房室模型分析,求得DP在大鼠体内主要的药动学参数,并对其进行统计分析。结果2组大鼠DP药动学参数t21、AUC0→t、MRT0→7h、Vz/F、CL/F、tmax、ρmax差异均无统计学意义(Ρ>0.05)。但氨溴索与DP合并使用时,DP代谢产物TP的AUC0-7h2组差异具有统计学意义(Ρ<0.05),合用组提高了38.77%。结论氨溴索对DP在大鼠体内动力学过程无影响,但有减缓DP的代谢产物TP代谢的趋势,两药同时使用时,应注意监测TP的血药浓度。 A/M To study the effect of ambroxol injection on pharmacokinetics of doxophylline in rats. METHODS A total of 16 rats were divided into two groups:one was administrated with doxophylline individually and another with the combination of doxophylline and ambroxol. Concentrations of doxophylline and its metabolite theophylline in plasma were determined by HPLC. The plasma concentration-time data of doxophylline were analyzed by DAS program according to no-compamnent model. The main pharmacokinetic parameters of doxophylline were obtained and compared with SPSS software between two groups. RESULTS No significant differences were found on the main phannacokinetie parameters such as t1/2, AUC0→t, MRT0→7 h, Vz/F,CL/F, tmax and ρmax, of doxophylline between two groups( P 〉 0.05). But the AUC of doxophylline' s, metabolite theophylline after co-administration showed significant difference( P 〈 0.05)and it was increased by 38.77 %. CONCLUSION There is no effect of ambroxol on phannacokinetics of doxophylline in rats. But ambroxol can slowed down the metabolism of theophylline. The concentration of theophylline in plasma should be monitored when doxophylline and ambroxol are co-administered.
出处 《中国临床药学杂志》 CAS 2009年第5期278-282,共5页 Chinese Journal of Clinical Pharmacy
关键词 多索茶碱 茶碱 氨溴索 药动学 HPLC doxophyUine theophylline ambroxol pharmacokinefics HPLC
  • 相关文献

参考文献6

二级参考文献16

  • 1施毅,康晓明,储小曼,夏锡荣,卓海通,刘堃.环丙沙星和氧氟沙星对氨茶碱药代动力学的影响[J].中国临床药理学杂志,1994,10(4):206-210. 被引量:13
  • 2钟淑卿 莫红樱 张永昶 等.氟喹诺酮类对缓释茶碱茶喘平药动学的影响[J].中华结核和呼吸杂志,1995,18(4):240-240.
  • 3法国OVP维德.维德临床用药年鉴[M].北京:中信出版社,1999.223.
  • 4李家泰.治疗呼吸系统疾病的药物[A]..临床药理学:第2版[C].北京:人民卫生出版社,1998.1125.
  • 5Stab H. Moxifloxacin-review of clinical pharrnacokinetics metabolism and excretion,Poster at First International Moxiflixacia Symposium[ C ]. Berlin: Bayer, 1993,3 : 1986.
  • 6Stass H, Dalhoff A, Kubitza D, et al. Pharmacokinetics, safety,and tolerbility of ascending single doses of Moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects[J]. Antimicrob Agents Chemothe , 1998,42(8) :2060.
  • 7Villani F, Maria PD, Ronchi E, et al. Oral doxophylline in patients with chronic obstructive pulmonary disease[J]. Int J Clin Pharmacol Ther, 1997,35(3) : 107.
  • 8Wise R. Areview of the clinical pharmacology of moxifloxaein, a new 8-methoxyquinμLone, and its potentiμL relation to therapeutic effieacy[ J ]. Clin Druw lnvest. 1999.17 (5) : 365.
  • 9Franzone JS, Cravanzola C, Masera F. Preliminary studies of the absorption, distribution and excretion of 2-( 7 '-theophyllinernethyl)-1, 3-dioxolane in rat[J]. Farmaco ( Sci ), 1981,36(3) :220.
  • 10Grosa G, Franzone JS, Biglino G. Metabolism of doxofylline by rat liver microsomes[J]. Am Sci Pharmacol & Exp Ther,1986,14(2) :33.

共引文献30

同被引文献77

  • 1彭婕,郑闻.莫西沙星口服致过敏性休克[J].药物不良反应杂志,2006,8(5):385-385. 被引量:23
  • 2王春霞,田秀明.多索茶碱临床副作用评价[J].临床肺科杂志,2007,12(1):37-37. 被引量:38
  • 3黄碧云,邹巧根,相秉仁.HPLC法测定注射用丹参酮Ⅱ_A磺酸钠含量及其有关物质[J].中国药科大学学报,2007,38(1):47-50. 被引量:9
  • 4中国药典临床用药须知[S].2005年版.北京:人民卫生出版社,2005.479.
  • 5林聪丽,张春红.莫西沙星引起严重中枢神经系统反应2例[J].药学实践杂志,2007,25(4):266-266. 被引量:20
  • 6Buzsaki G, Smith A., .Berger S, et al. Petit mal epilepsy and parkinsonian tremor: hypothesis of a common pacemaker [J]. Neuroscience, 1990, 36(1): 1-14.
  • 7Page CP. Doxofylline : a " novofylline" [ J ]. Pulmonary pharmacology & therapeutics, 2010, 23 (4): 231-234.
  • 8Goldstein MF, Chervinsky P. Efficacy and safety of doxofyl- line compared to theophylline in chronic reversible asthma-a double blind, randomized, placebo controlled-muhicentre clinical trial[J]. Med Sci Monit, 2002,8:297-304.
  • 9韦凤,胡稀,陈剑波.65例头孢吡肟致中枢神经系统损害文献分析[J].中国药物应用与监测,2013,10(3):150-153.
  • 10TANG J, ZHOU X, JI H, et al. Effects of ephedra water decoction and cough tablets containing ephedra and liquorice on CYP1A2 and the pharmacokinetics of theophylline in rats [J]. Phytother. Res, 2012, 26(3): 470-474.

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部